ResearcherNational Cancer Centre JapanActive in the last 2 years
Hirokazu Shoji
Matched on ORCID iD 0000-0002-8922-5227; OpenAlex author ID A5008535163. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 40
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2600752↗
- CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. Co-author DOI 10.1002/ijc.31900↗
- Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2018.06.003↗
- Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms. Co-author DOI 10.1038/srep15921↗
Closest collaborators
The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazufumi Honda · 3 shared papers, 2015–2019 · strength 0.21
- Paper Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer. DOI 10.1016/j.pan.2018.06.003↗
- Paper CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. DOI 10.1002/ijc.31900↗
- Paper Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibo… DOI 10.1038/srep15921↗
- Wungki Park · 1 shared paper, 2026 · strength 0.19
- Antoîne Italiano · 1 shared paper, 2026 · strength 0.19
- Antoine Hollebecque · 1 shared paper, 2026 · strength 0.19
- Makoto Ueno · 1 shared paper, 2026 · strength 0.19
- Anup Kasi · 1 shared paper, 2026 · strength 0.19
- Patricia Mucci LoRusso · 1 shared paper, 2026 · strength 0.19
- Jordan D. Berlin · 1 shared paper, 2026 · strength 0.19
- Pasi Antero Janne · 1 shared paper, 2026 · strength 0.19
- Christos K Fountzilas · 1 shared paper, 2026 · strength 0.19
- Philippe Alexandre Cassier · 1 shared paper, 2026 · strength 0.19
- Jonathan Wade Goldman · 1 shared paper, 2026 · strength 0.19
- Benoît You · 1 shared paper, 2026 · strength 0.19
- Alexander I. Spira · 1 shared paper, 2026 · strength 0.19
- Teresa Mercade Macarulla · 1 shared paper, 2026 · strength 0.19
- Hideki Ueno · 1 shared paper, 2018 · strength 0.12
- H. Bas Bueno-de-Mesquita · 1 shared paper, 2019 · strength 0.06
- Eric J. Duell · 1 shared paper, 2019 · strength 0.06
- Paolo Vineis · 1 shared paper, 2019 · strength 0.06
- Vinciane Rebours · 1 shared paper, 2019 · strength 0.06
- Paul Brennan · 1 shared paper, 2019 · strength 0.06
- Federico Canzian · 1 shared paper, 2019 · strength 0.06
- Verena Andrea Katzke · 1 shared paper, 2019 · strength 0.06
- Konstantinos K. Tsilidis · 1 shared paper, 2019 · strength 0.06
- Malin Sund · 1 shared paper, 2019 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.